Search
for
Sort by
Research 61–90 of 773
- Curcumin derivatives inhibit testicular 17β-hydroxysteroid dehydrogenase 3
- Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Glioblastoma cells express crucial enzymes involved in androgen synthesis: 3β‐hydroxysteroid dehydrogenase, 17‐20α‐hydroxylase, 17β‐hydroxysteroid dehydrogenase and 5α‐reductase
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Effect of <i>Eurycoma longifolia</i> Extract on Testosterone Synthesis in TM3 Leydig Cells under Oxidative Stress
- Does Dietary Fatty Acid, Decanoic Acid, Prevent Polycystic Ovary Syndrome?
- 258 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells
- Delayed Diagnosis of Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
- Effect of Nymphaea caerulea Flower Extract on Improving Scalp Diseases
- A Platform for Determining Medicinal Plants with Targeted 17β-Hydroxysteroid Dehydrogenase Modulation for Possible Hair Loss Prevention
- In-silico screening of potential anti-androgenic and anti-estrogenic phytocompounds from Saraca asoca for polycystic ovary syndrome treatment
- 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells
- Expression of mRNA for androgen receptor, 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase in human dermal papilla cells
- 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population.
- Idiopathic hirsutism: Is it really idiopathic or is it misnomer?
- MALE PSEUDOHERMAPHRODITISM DUE TO 17β-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY: STUDIES ON THE NATURAL HISTORY OF THE DEFECT AND EFFECT OF ANDROGENS ON GENDER ROLE
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
- Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency: Studies on the natural history of the defect and effect of androgens on gender role
- Natural potent androgens: Lessons from human genetic models
- Effect of 3-Beta Hydroxysteroid Dehydrogenase on Serum Testosterone Level in Obese Women With Polycystic Ovary Syndrome
- Trichoscopic Markers as Predictors of Treatment Response in Androgenetic Alopecia: A Systematic Review
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.
- (369) Physician Insights into the Safety of Flibanserin for the Treatment of Sexual Dysfunction in Men
- (423) A Case Series of Successful Off-label Use of Flibanserin
- Trichoscopic criteria of different stages of male pattern hair loss